Muscle Pharm Corporation (MSLPQ)

[StocksAnonymous]

Some key Takeaways:

The Buyout Thesis:

Applying the average acquisition P/S multiple to MSLP (full-year revenue midpoint of $190 million) would yield a buyout price of $435.1 million, or $31.76 per share (assuming 13.7 million shares outstanding). Even using the more conservative median P/S buyout multiple of 2 would yield a buyout price of $380 million, or $27.74 per share. This is roughly 100% upside from current levels. Glanbia PLC and Post Holdings appear to be the most likely potential acquirers given their size and history of acquisitions in the supplement and nutrition industry.

Gross Margin, Discounts, Sales:



Insider Buying:






Share Price Holding up while Russell and S&P Sold off:



Sports Drinks & COCO Water Market: